Fed Trapped at 3.50-3.75% as Iran Conflict Ignites Oil-Fueled Inflation Shock

The Fed's 3.50-3.75% rate hold faces stress tests as Middle East conflict drives energy volatility and sticky inflation above the 2% target.

Vertex's Kidney Trial Win: Progress or Peril for Biotech Bulls?

Vertex Pharmaceuticals surged 4% on rare disease trial success, but investors should weigh pipeline risks against diversification hopes.

---

TSX Materials Rally Outpaces US Markets as Gold Hits Record Highs

Oracle's Cloud Ascendancy: Can It Weather the AI Storm?

Oracle's Q3 earnings beat underscores its successful cloud pivot, but can it maintain momentum amid intensifying AI infrastructure demands?